Published in Blood on March 08, 2007
Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood (2011) 3.25
No evidence for tissue factor on platelets. Blood (2010) 2.31
Microparticles in hemostasis and thrombosis. Circ Res (2011) 2.26
Anucleate platelets generate progeny. Blood (2010) 2.24
Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood (2010) 2.10
Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica (2009) 1.65
Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol (2008) 1.47
Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost (2008) 1.38
Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol (2008) 1.38
Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol (2009) 1.32
Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol (2010) 1.29
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2011) 1.26
Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol (2008) 1.24
Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant (2010) 1.21
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. J Thromb Haemost (2009) 1.20
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost (2011) 1.15
Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr (2012) 1.11
Role of tissue factor in venous thrombosis. Annu Rev Physiol (2011) 1.09
Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res (2010) 1.09
The nature of the stable blood clot procoagulant activities. J Biol Chem (2008) 1.08
Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidic model of vessel injury. Bioconjug Chem (2011) 1.08
Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res (2009) 1.04
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res (2008) 1.04
The role of carrier number on the procoagulant activity of tissue factor in blood and plasma. Phys Biol (2011) 1.03
Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans. J Thromb Haemost (2008) 1.02
Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology? Crit Care (2013) 1.02
Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact? Nat Rev Cardiol (2009) 0.94
Platelet mRNA: the meaning behind the message. Curr Opin Hematol (2012) 0.93
Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes (2010) 0.93
Functional expression of IgA receptor FcalphaRI on human platelets. J Leukoc Biol (2008) 0.92
Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis (2010) 0.91
Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer (2015) 0.87
Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med (2012) 0.87
Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. Mediterr J Hematol Infect Dis (2010) 0.86
Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Lupus (2010) 0.86
Evidence for enhanced tissue factor expression in age-related macular degeneration. Lab Invest (2010) 0.86
Microvesicles at the crossroads between infection and cardiovascular diseases. J Cardiovasc Pharmacol (2012) 0.86
The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects. PPAR Res (2008) 0.85
Tissue factor: past, present, and future. Arterioscler Thromb Vasc Biol (2009) 0.84
Tissue Factor Expression on Platelet Surface during Preparation and Storage of Platelet Concentrates. Transfus Med Hemother (2013) 0.83
Inhibition of angiogenesis by platelets in systemic sclerosis patients. Arthritis Res Ther (2015) 0.82
Tissue factor structure and function. Scientifica (Cairo) (2012) 0.78
Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets. J Thromb Haemost (2011) 0.78
Tissue factor controversies. Thromb Res (2012) 0.77
Platelets do not express the oxidized or reduced forms of tissue factor. Biochim Biophys Acta (2013) 0.77
Inhibitors of the initiation of coagulation. Br J Clin Pharmacol (2011) 0.76
Comprehensive Proteome Profiling of Platelet Identified a Protein Profile Predictive of Responses to An Antiplatelet Agent Sarpogrelate. Mol Cell Proteomics (2016) 0.75
Correlation between factor (F)XIa, FIXa and tissue factor and trauma severity. J Trauma Acute Care Surg (2017) 0.75
Characterizing the Mechanistic Pathways of the Instant Blood-Mediated Inflammatory Reaction in Xenogeneic Neonatal Islet Cell Transplantation. Transplant Direct (2016) 0.75
Tissue factor with age-related macular degeneration. Int J Ophthalmol (2012) 0.75
A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans. PLoS One (2016) 0.75
Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4. PLoS One (2017) 0.75
Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin. Sci Rep (2017) 0.75
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood (2002) 2.37
High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica (2007) 1.82
Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost (2006) 1.25
Beginning literacy: links among teacher knowledge, teacher practice, and student learning. J Learn Disabil (2004) 1.19
C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia". Int J Cardiol (2005) 1.12
Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users. Thromb Res (2011) 0.94
Novel loci involved in platelet function and platelet count identified by a genome-wide study performed in children. Haematologica (2011) 0.93
Health impact of Mediterranean diets in food at work. Public Health Nutr (2009) 0.91
Is my patient a bleeder? A diagnostic framework for mild bleeding disorders. Hematology Am Soc Hematol Educ Program (2012) 0.91
The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost (2009) 0.87
Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. J Clin Lab Anal (2003) 0.87
Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis. J Clin Lab Anal (2005) 0.84
Tissue factor storage, synthesis and function in normal and activated human platelets. Thromb Res (2008) 0.84
Platelet activation in chronic cocaine users: effect of short term abstinence. Platelets (2011) 0.83
Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation. J Thromb Thrombolysis (2012) 0.82
[Normal plasma insulin and HOMA values among Chilean children and adolescents]. Rev Med Chil (2012) 0.82
Tranexamic acid and uremic bleeding: evidence-based treatment recommendations. Nat Clin Pract Nephrol (2007) 0.81
Platelet aging in vivo is associated with activation of apoptotic pathways: studies in a model of suppressed thrombopoiesis in dogs. Thromb Haemost (2002) 0.81
Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible. Semin Thromb Hemost (2008) 0.80
Pregnant rats treated with a serotonin precursor have reduced fetal weight and lower plasma volume and kallikrein levels. Hypertension (2007) 0.79
Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause. Br J Haematol (2009) 0.79
[A novel method for targeting and characterizing healthy older people]. Rev Med Chil (2010) 0.79
Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. J Lab Clin Med (2002) 0.78
Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol (2009) 0.78
Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages. Clin Chim Acta (2008) 0.78
[Thrombotic thrombocytopenic purpura: experience in 18 cases and literature review]. Rev Med Chil (2009) 0.78
Mediterranean food and diets, global resource for the control of metabolic syndrome and chronic diseases. World Rev Nutr Diet (2008) 0.78
Aortic stenosis and acquired von Willebrand disease: lack of association. J Cardiothorac Vasc Anesth (2011) 0.78
Val/Leu247 and Trp/Ser316 polymorphisms in beta 2 glycoprotein I and their association with thrombosis in unselected Chilean patients. Clin Rheumatol (2006) 0.77
Influence of the F12 -4 C>T polymorphism on hemostatic tests. Blood Coagul Fibrinolysis (2010) 0.77
Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin. Atherosclerosis (2016) 0.77
Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis. Clin Rheumatol (2004) 0.77
[Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors]. Rev Med Chil (2013) 0.77
[Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis]. Rev Med Chil (2006) 0.76
GUTI: a new antigen in the Cromer blood group system. Transfusion (2003) 0.76
Blood cells cholinesterase activity in early stage Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord (2005) 0.76
Changes in regional cerebral blood flow are associated with endothelial dysfunction markers in cocaine-dependent patients under recent abstinence. J Addict Med (2015) 0.76
[New oral anticoagulant drugs]. Rev Med Chil (2012) 0.75
Protective Mechanisms of S. lycopersicum Aqueous Fraction (Nucleosides and Flavonoids) on Platelet Activation and Thrombus Formation: In Vitro, Ex Vivo and In Vivo Studies. Evid Based Complement Alternat Med (2013) 0.75
Salmonella enterica serovar Typhi O:1,9,12 polysaccharide-protein conjugate as a diagnostic tool for typhoid fever. J Clin Microbiol (2005) 0.75
[Prevalence of Gilbert syndrome and its genetic determinants in Chile]. Rev Med Chil (2013) 0.75
Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis. Nephron (2002) 0.75
[Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism]. Rev Med Chil (2002) 0.75
[Cocaine-induced vascular damage. Report of one case]. Rev Med Chil (2012) 0.75
[Indications, adverse effects and results of plasmapheresis in critical care patients]. Rev Med Chil (2006) 0.75
[New series on Clinical Laboratory in Revista Médica de Chile]. Rev Med Chil (2009) 0.75
[Sézary syndrome treated with extracorporeal photopheresis: Report of one case]. Rev Med Chil (2015) 0.75
Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid. Platelets (2011) 0.75
Blood component usage during extracorporeal membrane oxygenation: experience in 98 patients at a Latin-American tertiary hospital. Int J Artif Organs (2014) 0.75
[Serum lipid levels in a group of cocaine dependent subjects in recent abstinence]. Rev Med Chil (2015) 0.75
Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4. PLoS One (2017) 0.75
Platelet membrane glycoprotein polymorphisms do not influence the clinical expressivity of von Willebrand disease type 1. Thromb Haemost (2003) 0.75
Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders. Ann Hematol (2010) 0.75
High plasma levels of lipoprotein(a) in uremic patients are related to markers of inflammation, and to activated, not impaired, fibrinolysis. Thromb Haemost (2002) 0.75
Direct identification of staphylococcus aureus from positive blood culture specimens with a rapid test. J Med Microbiol (2002) 0.75
[Primary thrombophilia. Report of 93 cases and 12 asymptomatic relatives]. Rev Med Chil (2004) 0.75
Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages. Pathophysiol Haemost Thromb (2003) 0.75
[Introns 1 and 22 inversions and F8 gene sequencing for molecular diagnosis of hemophilia A in Chile]. Rev Med Chil (2011) 0.75